What is the recommended tapering schedule for fluoxetine (selective serotonin reuptake inhibitor) when reducing the dose from 60mg to 40mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

When tapering fluoxetine from 60mg to 40mg, a hyperbolic and slow tapering schedule is recommended to minimize withdrawal symptoms, as suggested by the most recent and highest quality study 1.

Tapering Schedule

The tapering schedule should be individualized, but a general approach can be applied.

  • Reduce the dose by small increments, such as 5-10mg, every 2-4 weeks.
  • Monitor the patient for potential discontinuation symptoms, such as dizziness, headache, nausea, or mood changes.
  • If symptoms occur, slow the tapering schedule.

Pharmacological Properties

Fluoxetine has a long half-life (2-3 days for the parent drug and 7-9 days for its active metabolite norfluoxetine), which creates a natural tapering effect and reduces the risk of discontinuation symptoms 2.

Clinical Considerations

Some patients may tolerate a direct reduction from 60mg to 40mg without an intermediate step due to this pharmacological property. Always consult with the prescribing healthcare provider before making any medication changes, as individual factors may require personalized adjustments to this general tapering approach.

Key Points

  • Hyperbolic and slow tapering schedule recommended 1
  • Monitor for discontinuation symptoms and adjust tapering schedule as needed
  • Fluoxetine's long half-life reduces the risk of discontinuation symptoms 2
  • Individualized tapering schedule may be necessary based on patient factors

References

Research

Fluoxetine once every third day in the treatment of major depressive disorder.

European archives of psychiatry and clinical neuroscience, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.